| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 31 |
| Sex | Both Genders |
| Age Range | 1-6, 7-12, 13-17 |
Eight weeks supplementation of NAC as adjuvant to risperidone therapy in children with autism was able to reduce irritability relative to placebo, but the other measured parameters (Lethargy and Social Withdrawal, Stereotypic Behavior, Hyperactivity, and Noncompliance) were not affected by treatment.
